Relationship between dose prescription methods and local control rate in stereotactic body radiotherapy for early stage non-small-cell lung cancer: systematic review …

T Eriguchi, A Takeda, T Nemoto, Y Tsurugai, N Sanuki… - Cancers, 2022 - mdpi.com
Simple Summary Stereotactic body radiotherapy (SBRT) is a standard treatment for
inoperable early stage non-small-cell lung cancer (ES-NSCLC), and good local control and …

Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer

Z Wu, S Man, R Sun, Z Li, Y Wu, D Zuo - International …, 2020 - Elsevier
Chemotherapy and targeted therapy have significantly improved the progression of non-
small cell lung cancer (NSCLC), but patients are inevitably suffering from drug resistance …

Individualized stereotactic ablative radiotherapy for lung tumors: the iSABR phase 2 nonrandomized controlled trial

MF Gensheimer, H Gee, H Shirato, H Taguchi… - JAMA …, 2023 - jamanetwork.com
Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures …

Treatment plan quality during online adaptive re-planning

JE van Timmeren, M Chamberlain, J Krayenbuehl… - Radiation …, 2020 - Springer
Background Online adaptive radiotherapy is intended to prevent plan degradation caused
by inter-fractional tumor volume and shape changes, but time limitations make online re …

Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations

S Regnery, C Buchele, F Weykamp, M Pohl… - Frontiers in …, 2022 - frontiersin.org
Purpose To explore the benefit of adaptive magnetic resonance-guided stereotactic body
radiotherapy (MRgSBRT) for treatment of lung tumors in different locations with a focus on …

Stereotactic body radiation therapy with a high maximum dose improves local control, cancer-specific death, and overall survival in peripheral early-stage non-small …

Y Tateishi, A Takeda, N Horita, Y Tsurugai… - International Journal of …, 2021 - Elsevier
Purpose We investigated whether delivery of a high biologically effective dose (BED) to
primary tumors affects systemic outcomes of cancer-specific death (CSD) and overall …

[HTML][HTML] Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs …

P Hoegen, E Katsigiannopulos, C Buchele… - Clinical and translational …, 2023 - Elsevier
Abstract Purpose/Objective To evaluate the potential of stereotactic magnetic resonance-
guided online adaptive radiotherapy (SMART) to fulfill dose recommendations for …

Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic …

M Avanzo, V Gagliardi, J Stancanello, O Blanck… - Medical …, 2021 - Wiley Online Library
Purpose The aim of this study is to improve the performance of machine learning (ML)
models in predicting response of non‐small cell lung cancer (NSCLC) to stereotactic body …

Deep learning-guided dosimetry for mitigating local failure of patients with non-small cell lung cancer receiving stereotactic body radiation therapy

D Dudas, PG Saghand, TJ Dilling, BA Perez… - International Journal of …, 2024 - Elsevier
Purpose Non-small cell lung cancer (NSCLC) stereotactic body radiation therapy with 50
Gy/5 fractions is sometimes considered controversial, as the nominal biologically effective …

To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes

S Regnery, E Katsigiannopulos, P Hoegen… - Lung Cancer, 2023 - Elsevier
Background Stereotactic radiotherapy of ultracentral lung tumors (ULT) is challenging as it
may cause overdoses to sensitive mediastinal organs with severe complications. We aimed …